Streetbeat News

Equity Actions

DD

DuPont De Nemours shares are trading higher following the announcement of a plan to separate into three publicly traded companies. The company also reaffirmed its Q2 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:33 am

NVDA

NVIDIA shares are trading higher following better-than-expected Q1 2025 financial results and strong Q2 2025 revenue guidance. The company also announced a 10-for-1 forward stock split and an increased quarterly dividend per share on a post-split basis.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:32 am

AJX

Great Ajax Corp has filed for a shelf registration of up to 12 million shares of common stock by selling stockholders, as indicated in their S-3 filing.

Portfolio Pulse from Charles Gross

May 23, 2024 | 10:08 am

XP

XP Inc. has announced a repurchase plan for up to the amount in dollars equivalent to R$1.0 billion of its outstanding Class A common shares.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 10:07 am

NVX

NOVONIX CFO Nick Liveris is set to retire and transition to a Non-Executive Director role.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 8:13 am

FLFV

Feutune Light Acquisition, a blank check company, has extended its deadline for an initial business combination to June 21, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 7:42 am

CCEP

Coca-Cola Europacific Partners has appointed Ed Walker as the new Chief Financial Officer, effective July 1. This leadership change could impact the company's financial strategies and performance.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 6:55 am

FIHL

Fidelis Insurance Group has priced a secondary offering of 9 million common shares at $167 per share. The company itself is not selling any shares and will not receive any proceeds from this sale. The offering is expected to close on May 28, 2024, subject to customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 6:43 am

BOW

Bowhead Specialty has priced its upsized initial public offering (IPO) of 7,529,412 shares at $17 per share, expecting to raise $128 million before expenses.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 6:30 am

CYTK

Cytokinetics has priced a public offering of 9,803,922 shares of common stock at $51 per share, expecting to raise approximately $500 million in gross proceeds. The offering is anticipated to close on May 28, 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 6:17 am